Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry
- PMID: 34269853
- PMCID: PMC8284037
- DOI: 10.1007/s00134-021-06471-6
Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry
Conflict of interest statement
JP has received personal fees from Gilead Sciences and Pfizer, research funding from MSD and is stoke holder of AbbVie Inc and Novo Nordisk. JW reports grants and personal fees from Gilead and Pfizer: investigator-initiated grants, personal fees and also on-financial support from MSD. DRG reports an unconditional grant from Correvio Italia and a grant for his institution by Pfizer Inc. KL received consultancy fees from SMB Laboratories Brussels, MSD and Gilead, travel support from Pfizer, speaker fees from FUJIFILM WAKO, Pfizer and Gilead and a service fee from Thermo fisher Scientific. MH received research funding from Gilead Sciences, Astellas, Scynexis, F2G and Pfizer.
Comment in
-
COVID-19-associated invasive pulmonary aspergillosis: high incidence or difficult diagnosis?Intensive Care Med. 2021 Nov;47(11):1337-1338. doi: 10.1007/s00134-021-06499-8. Epub 2021 Aug 3. Intensive Care Med. 2021. PMID: 34342659 Free PMC article. No abstract available.
-
Inhaled amphotericin B lipid complex for prophylaxis against COVID-19-associated invasive pulmonary aspergillosis.Intensive Care Med. 2022 Mar;48(3):360-361. doi: 10.1007/s00134-021-06603-y. Epub 2021 Dec 23. Intensive Care Med. 2022. PMID: 34940907 Free PMC article. No abstract available.
References
-
- Verweij PE, Rijnders BJA, Brüggemann RJM, Azoulay E, Bassetti M, Blot S, Calandra T, Clancy CJ, Cornely OA, Chiller T, Depuydt P, Giacobbe DR, Janssen NAF, Kullberg B-J, Lagrou K, Lass-Flörl C, Lewis RE, Liu PW-L, Lortholary O, Maertens J, Martin-Loeches I, Nguyen MH, Patterson TF, Rogers TR, Schouten JA, Spriet I, Vanderbeke L, Wauters J, van de Veerdonk FL. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46:1524–1535. doi: 10.1007/s00134-020-06091-6. - DOI - PMC - PubMed
-
- Salmanton-García J, Sprute R, Stemler J, Bartoletti M, Dupont D, Valerio M, Garcia-Vidal C, Falces-Romero I, Machado M, de la Villa S, Schroeder M, Hoyo I, Hanses F, Ferreira-Paim K, Giacobbe DR, Meis JF, Gangneux JP, Rodríguez-Guardado A, Antinori S, Sal E, Malaj X, Seidel D, Cornely OA, Koehler P. COVID-19-associated pulmonary aspergillosis, March-August 2020. Emerg Infect Dis. 2021;27:1077–1086. doi: 10.3201/eid2704.204895. - DOI - PMC - PubMed
-
- Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, Klimko N, Lass-Florl C, Oladele RO, Vinh DC, Zhu LP, Boll B, Bruggemann R, Gangneux JP, Perfect JR, Patterson TF, Persigehl T, Meis JF, Ostrosky-Zeichner L, White PL, Verweij PE, Cornely OA, European Confederation of Medical M, International Society for Human Animal M, Asia Fungal Working G, Group ILIW, Group IPAMW, European Society for Clinical M, Infectious Diseases Fungal Infection Study G, Patients ESGfIiCI, Interregional Association of Clinical M, Antimicrobial C, Medical Mycology Society of N, Medical Mycology Society of China Medicine Education A, Infectious Diseases Working Party of the German Society for H, Medical O, Association of Medical M, Infectious Disease C, (2020) Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 21(6), e149–e162 - PubMed
-
- Hoenigl M (2020) Invasive fungal disease complicating COVID-19: when it rains it pours. Clin Infect Dis Off Publ Infect Dis Soc Am. 10.1093/cid/ciaa1342
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical